Clients

Arch Therapeutics, Inc.

Company Snapshot: Arch Therapeutics, Inc.

ARTH
Last Change Volume High Low

Company Overview

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding (hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products based on an innovative self-assembling peptide technology platform to make surgery and interventional care faster and safer for patients. Arch's flagship development stage product candidate, known as AC5 Surgical Hemostatic Device™, is being designed to achieve hemostasis in minimally invasive and open surgical procedures.

Featured Documents

Client News

  1. Mar 12 2018 Arch Therapeutics Provides Update on 510(k)
  2. Mar 5 2018 Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018
  3. Jan 2 2018 Arch Therapeutics to Provide Corporate Update at The 10th Annual Biotech Showcase™ 2018 Conference on January 8th, 2018
  4. Dec 18 2017 Arch Therapeutics Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA